Global NAD+ Enhancer Market Research Report 2025

Major Trends 

The global NAD+ (Nicotinamide Adenine Dinucleotide) enhancer market is growing as a result of the increasing focus on anti-aging and longevity treatments. NAD+ is a coenzyme that plays a crucial role in energy production and metabolic processes within cells. As researchers uncover the potential benefits of boosting NAD+ levels in the body, particularly in terms of extending lifespan, improving cellular repair, and preventing age-related diseases, there is growing interest in NAD+ enhancer supplements. The rising awareness of the importance of cellular health and longevity, along with the growing trend of self-care and wellness, is driving the demand for NAD+ enhancers in the health and wellness market.

NAD+ Enhancer Market Trends

Rising Interest in Anti-Aging and Longevity Supplements

The growing interest in anti-aging and longevity treatments is one of the primary drivers of the NAD+ enhancer market. NAD+ enhancers, such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), are being increasingly used as dietary supplements to boost NAD+ levels in the body and support overall health. These supplements are believed to have a range of benefits, including improving energy levels, promoting better sleep, and enhancing cognitive function. As consumers seek ways to slow down the aging process and improve their quality of life, the demand for NAD+ enhancers is expected to rise.

Scientific Research on NAD+ and Health Benefits

Advances in scientific research on NAD+ and its role in cellular health and longevity are fueling the growth of the market. Studies have shown that NAD+ levels decline with age, and replenishing these levels may help combat age-related conditions such as cognitive decline, cardiovascular disease, and metabolic disorders. The increasing body of research supporting the health benefits of NAD+ enhancers is driving their adoption, as consumers look for scientifically-backed solutions to improve their health and longevity.

Growing Wellness and Preventive Healthcare Trends

As preventive healthcare becomes a priority for consumers, there is an increasing demand for supplements and products that promote long-term health and well-being. NAD+ enhancers are positioned as a solution to improve cellular health and prevent age-related diseases, making them an attractive option for consumers who are focused on wellness and prevention. This trend is contributing to the growth of the NAD+ enhancer market, as consumers incorporate these supplements into their daily routines.

Integration of NAD+ Enhancers in Anti-Aging Skincare Products

The use of NAD+ enhancers is expanding beyond dietary supplements to include anti-aging skincare products. NAD+ boosters are being integrated into creams, serums, and other topical skincare products due to their potential to support skin regeneration and reduce the appearance of wrinkles and fine lines. The incorporation of NAD+ enhancers into the skincare market is helping to drive further growth, as consumers seek innovative products that promote youthful, healthy skin.

NAD+ Enhancer Market Share

For the NAD+ Enhancer industry, the market is high concentrated. GeneHarbor, Chromade and MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical) are the leading companies globally. The Top 5 players listed in the report accounted for about 41% of the market. There are several types of NAD+ Enhancer. The market can be segmented into, Content ＜98%, Content ≥98%. Content ≥98% are the most commonly used type, accounting for 93% of the market share in 2022. By application, Health Care Products are the largest downstream application area, with a consumption market share of 84% in 2022. 

Report Scope

This report aims to provide a comprehensive presentation of the global market for NAD+ Enhancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NAD+ Enhancer.

The NAD+ Enhancer market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global NAD+ Enhancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the NAD+ Enhancer manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of NAD+ Enhancer Market Report

Core Chapters

1.1 Product Definition

1.2 NAD+ Enhancer by Type

1.2.1 Global NAD+ Enhancer Market Value Comparison by Type (2024 VS 2031)

1.2.2 Content ＜98%

1.2.3 Content ≥98%

1.3 NAD+ Enhancer by Application

1.3.1 Global NAD+ Enhancer Market Value by Application (2024 VS 2031)

1.3.2 Health Care Products

1.3.3 ClinicsBeauty Products

1.3.4 Others

1.4 Global NAD+ Enhancer Market Size Estimates and Forecasts

1.4.1 Global NAD+ Enhancer Revenue 2020-2031

1.4.2 Global NAD+ Enhancer Sales 2020-2031

1.4.3 Global NAD+ Enhancer Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2.1 Global NAD+ Enhancer Sales Market Share by Manufacturers (2020-2025)

2.2 Global NAD+ Enhancer Revenue Market Share by Manufacturers (2020-2025)

2.3 Global NAD+ Enhancer Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of NAD+ Enhancer, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of NAD+ Enhancer, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of NAD+ Enhancer, Product Type & Application

2.7 Global Key Manufacturers of NAD+ Enhancer, Date of Enter into This Industry

2.8 Global NAD+ Enhancer Market Competitive Situation and Trends

2.8.1 Global NAD+ Enhancer Market Concentration Rate

2.8.2 The Global 5 and 10 Largest NAD+ Enhancer Players Market Share by Revenue

2.8.3 Global NAD+ Enhancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global NAD+ Enhancer Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global NAD+ Enhancer Sales by Region: 2020-2031

3.2.1 Global NAD+ Enhancer Sales by Region: 2020-2025

3.2.2 Global NAD+ Enhancer Sales by Region: 2026-2031

3.3 Global NAD+ Enhancer Revenue by Region: 2020-2031

3.3.1 Global NAD+ Enhancer Revenue by Region: 2020-2025

3.3.2 Global NAD+ Enhancer Revenue by Region: 2026-2031

3.4 North America NAD+ Enhancer Market Facts & Figures by Country

3.4.1 North America NAD+ Enhancer Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America NAD+ Enhancer Sales by Country (2020-2031)

3.4.3 North America NAD+ Enhancer Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe NAD+ Enhancer Market Facts & Figures by Country

3.5.1 Europe NAD+ Enhancer Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe NAD+ Enhancer Sales by Country (2020-2031)

3.5.3 Europe NAD+ Enhancer Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific NAD+ Enhancer Market Facts & Figures by Region

3.6.1 Asia Pacific NAD+ Enhancer Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific NAD+ Enhancer Sales by Region (2020-2031)

3.6.3 Asia Pacific NAD+ Enhancer Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America NAD+ Enhancer Market Facts & Figures by Country

3.7.1 Latin America NAD+ Enhancer Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America NAD+ Enhancer Sales by Country (2020-2031)

3.7.3 Latin America NAD+ Enhancer Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa NAD+ Enhancer Market Facts & Figures by Country

3.8.1 Middle East and Africa NAD+ Enhancer Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa NAD+ Enhancer Sales by Country (2020-2031)

3.8.3 Middle East and Africa NAD+ Enhancer Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global NAD+ Enhancer Sales by Type (2020-2031)

4.1.1 Global NAD+ Enhancer Sales by Type (2020-2025)

4.1.2 Global NAD+ Enhancer Sales by Type (2026-2031)

4.1.3 Global NAD+ Enhancer Sales Market Share by Type (2020-2031)

4.2 Global NAD+ Enhancer Revenue by Type (2020-2031)

4.2.1 Global NAD+ Enhancer Revenue by Type (2020-2025)

4.2.2 Global NAD+ Enhancer Revenue by Type (2026-2031)

4.2.3 Global NAD+ Enhancer Revenue Market Share by Type (2020-2031)

4.3 Global NAD+ Enhancer Price by Type (2020-2031)

5.1 Global NAD+ Enhancer Sales by Application (2020-2031)

5.1.1 Global NAD+ Enhancer Sales by Application (2020-2025)

5.1.2 Global NAD+ Enhancer Sales by Application (2026-2031)

5.1.3 Global NAD+ Enhancer Sales Market Share by Application (2020-2031)

5.2 Global NAD+ Enhancer Revenue by Application (2020-2031)

5.2.1 Global NAD+ Enhancer Revenue by Application (2020-2025)

5.2.2 Global NAD+ Enhancer Revenue by Application (2026-2031)

5.2.3 Global NAD+ Enhancer Revenue Market Share by Application (2020-2031)

5.3 Global NAD+ Enhancer Price by Application (2020-2031)

6.1 GeneHarbor

6.1.1 GeneHarbor Company Information

6.1.2 GeneHarbor Description and Business Overview

6.1.3 GeneHarbor NAD+ Enhancer Sales, Revenue and Gross Margin (2020-2025)

6.1.4 GeneHarbor NAD+ Enhancer Product Portfolio

6.1.5 GeneHarbor Recent Developments/Updates

6.2 Chromadex

6.2.1 Chromadex Company Information

6.2.2 Chromadex Description and Business Overview

6.2.3 Chromadex NAD+ Enhancer Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Chromadex NAD+ Enhancer Product Portfolio

6.2.5 Chromadex Recent Developments/Updates

6.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)

6.3.1 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Company Information

6.3.2 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Description and Business Overview

6.3.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Product Portfolio

6.3.5 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Developments/Updates

6.4 Herbalmax

6.4.1 Herbalmax Company Information

6.4.2 Herbalmax Description and Business Overview

6.4.3 Herbalmax NAD+ Enhancer Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Herbalmax NAD+ Enhancer Product Portfolio

6.4.5 Herbalmax Recent Developments/Updates

6.5 EffePharm

6.5.1 EffePharm Company Information

6.5.2 EffePharm Description and Business Overview

6.5.3 EffePharm NAD+ Enhancer Sales, Revenue and Gross Margin (2020-2025)

6.5.4 EffePharm NAD+ Enhancer Product Portfolio

6.5.5 EffePharm Recent Developments/Updates

6.6 Kingdomway

6.6.1 Kingdomway Company Information

6.6.2 Kingdomway Description and Business Overview

6.6.3 Kingdomway NAD+ Enhancer Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Kingdomway NAD+ Enhancer Product Portfolio

6.6.5 Kingdomway Recent Developments/Updates

6.7 NOMON Co., Ltd. (Teijin)

6.7.1 NOMON Co., Ltd. (Teijin) Company Information

6.7.2 NOMON Co., Ltd. (Teijin) Description and Business Overview

6.7.3 NOMON Co., Ltd. (Teijin) NAD+ Enhancer Sales, Revenue and Gross Margin (2020-2025)

6.7.4 NOMON Co., Ltd. (Teijin) NAD+ Enhancer Product Portfolio

6.7.5 NOMON Co., Ltd. (Teijin) Recent Developments/Updates

6.8 CELFULL

6.8.1 CELFULL Company Information

6.8.2 CELFULL Description and Business Overview

6.8.3 CELFULL NAD+ Enhancer Sales, Revenue and Gross Margin (2020-2025)

6.8.4 CELFULL NAD+ Enhancer Product Portfolio

6.8.5 CELFULL Recent Developments/Updates

6.9 Bontac

6.9.1 Bontac Company Information

6.9.2 Bontac Description and Business Overview

6.9.3 Bontac NAD+ Enhancer Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Bontac NAD+ Enhancer Product Portfolio

6.9.5 Bontac Recent Developments/Updates

6.10 Genex Formulas

6.10.1 Genex Formulas Company Information

6.10.2 Genex Formulas Description and Business Overview

6.10.3 Genex Formulas NAD+ Enhancer Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Genex Formulas NAD+ Enhancer Product Portfolio

6.10.5 Genex Formulas Recent Developments/Updates

6.11 EZZ

6.11.1 EZZ Company Information

6.11.2 EZZ Description and Business Overview

6.11.3 EZZ NAD+ Enhancer Sales, Revenue and Gross Margin (2020-2025)

6.11.4 EZZ NAD+ Enhancer Product Portfolio

6.11.5 EZZ Recent Developments/Updates

6.12 Maac10 Formulas

6.12.1 Maac10 Formulas Company Information

6.12.2 Maac10 Formulas Description and Business Overview

6.12.3 Maac10 Formulas NAD+ Enhancer Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Maac10 Formulas NAD+ Enhancer Product Portfolio

6.12.5 Maac10 Formulas Recent Developments/Updates

6.13 Elysium Health

6.13.1 Elysium Health Company Information

6.13.2 Elysium Health Description and Business Overview

6.13.3 Elysium Health NAD+ Enhancer Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Elysium Health NAD+ Enhancer Product Portfolio

6.13.5 Elysium Health Recent Developments/Updates

7.1 NAD+ Enhancer Industry Chain Analysis

7.2 NAD+ Enhancer Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 NAD+ Enhancer Production Mode & Process Analysis

7.4 NAD+ Enhancer Sales and Marketing

7.4.1 NAD+ Enhancer Sales Channels

7.4.2 NAD+ Enhancer Distributors

7.5 NAD+ Enhancer Customer Analysis

8.1 NAD+ Enhancer Industry Trends

8.2 NAD+ Enhancer Market Drivers

8.3 NAD+ Enhancer Market Challenges

8.4 NAD+ Enhancer Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

 Table 1. Global NAD+ Enhancer Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

 Table 2. Global NAD+ Enhancer Market Value by Application (2024 VS 2031) & (US$ Million)

 Table 3. Global NAD+ Enhancer Market Competitive Situation by Manufacturers in 2024

 Table 4. Global NAD+ Enhancer Sales (K Units) of Key Manufacturers (2020-2025)

 Table 5. Global NAD+ Enhancer Sales Market Share by Manufacturers (2020-2025)

 Table 6. Global NAD+ Enhancer Revenue (US$ Million) by Manufacturers (2020-2025)

 Table 7. Global NAD+ Enhancer Revenue Share by Manufacturers (2020-2025)

 Table 8. Global Market NAD+ Enhancer Average Price (US$/Unit) of Key Manufacturers (2020-2025)

 Table 9. Global Key Players of NAD+ Enhancer, Industry Ranking, 2022 VS 2023 VS 2024

 Table 10. Global Key Manufacturers of NAD+ Enhancer, Manufacturing Sites & Headquarters

 Table 11. Global Key Manufacturers of NAD+ Enhancer, Product Type & Application

 Table 12. Global Key Manufacturers of NAD+ Enhancer, Date of Enter into This Industry

 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

 Table 14. Global NAD+ Enhancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NAD+ Enhancer as of 2024)

 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

 Table 16. Global NAD+ Enhancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

 Table 17. Global NAD+ Enhancer Sales by Region (2020-2025) & (K Units)

 Table 18. Global NAD+ Enhancer Sales Market Share by Region (2020-2025)

 Table 19. Global NAD+ Enhancer Sales by Region (2026-2031) & (K Units)

 Table 20. Global NAD+ Enhancer Sales Market Share by Region (2026-2031)

 Table 21. Global NAD+ Enhancer Revenue by Region (2020-2025) & (US$ Million)

 Table 22. Global NAD+ Enhancer Revenue Market Share by Region (2020-2025)

 Table 23. Global NAD+ Enhancer Revenue by Region (2026-2031) & (US$ Million)

 Table 24. Global NAD+ Enhancer Revenue Market Share by Region (2026-2031)

 Table 25. North America NAD+ Enhancer Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

 Table 26. North America NAD+ Enhancer Sales by Country (2020-2025) & (K Units)

 Table 27. North America NAD+ Enhancer Sales by Country (2026-2031) & (K Units)

 Table 28. North America NAD+ Enhancer Revenue by Country (2020-2025) & (US$ Million)

 Table 29. North America NAD+ Enhancer Revenue by Country (2026-2031) & (US$ Million)

 Table 30. Europe NAD+ Enhancer Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

 Table 31. Europe NAD+ Enhancer Sales by Country (2020-2025) & (K Units)

 Table 32. Europe NAD+ Enhancer Sales by Country (2026-2031) & (K Units)

 Table 33. Europe NAD+ Enhancer Revenue by Country (2020-2025) & (US$ Million)

 Table 34. Europe NAD+ Enhancer Revenue by Country (2026-2031) & (US$ Million)

 Table 35. Asia Pacific NAD+ Enhancer Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

 Table 36. Asia Pacific NAD+ Enhancer Sales by Region (2020-2025) & (K Units)

 Table 37. Asia Pacific NAD+ Enhancer Sales by Region (2026-2031) & (K Units)

 Table 38. Asia Pacific NAD+ Enhancer Revenue by Region (2020-2025) & (US$ Million)

 Table 39. Asia Pacific NAD+ Enhancer Revenue by Region (2026-2031) & (US$ Million)

 Table 40. Latin America NAD+ Enhancer Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

 Table 41. Latin America NAD+ Enhancer Sales by Country (2020-2025) & (K Units)

 Table 42. Latin America NAD+ Enhancer Sales by Country (2026-2031) & (K Units)

 Table 43. Latin America NAD+ Enhancer Revenue by Country (2020-2025) & (US$ Million)

 Table 44. Latin America NAD+ Enhancer Revenue by Country (2026-2031) & (US$ Million)

 Table 45. Middle East and Africa NAD+ Enhancer Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

 Table 46. Middle East and Africa NAD+ Enhancer Sales by Country (2020-2025) & (K Units)

 Table 47. Middle East and Africa NAD+ Enhancer Sales by Country (2026-2031) & (K Units)

 Table 48. Middle East and Africa NAD+ Enhancer Revenue by Country (2020-2025) & (US$ Million)

 Table 49. Middle East and Africa NAD+ Enhancer Revenue by Country (2026-2031) & (US$ Million)

 Table 50. Global NAD+ Enhancer Sales (K Units) by Type (2020-2025)

 Table 51. Global NAD+ Enhancer Sales (K Units) by Type (2026-2031)

 Table 52. Global NAD+ Enhancer Sales Market Share by Type (2020-2025)

 Table 53. Global NAD+ Enhancer Sales Market Share by Type (2026-2031)

 Table 54. Global NAD+ Enhancer Revenue (US$ Million) by Type (2020-2025)

 Table 55. Global NAD+ Enhancer Revenue (US$ Million) by Type (2026-2031)

 Table 56. Global NAD+ Enhancer Revenue Market Share by Type (2020-2025)

 Table 57. Global NAD+ Enhancer Revenue Market Share by Type (2026-2031)

 Table 58. Global NAD+ Enhancer Price (US$/Unit) by Type (2020-2025)

 Table 59. Global NAD+ Enhancer Price (US$/Unit) by Type (2026-2031)

 Table 60. Global NAD+ Enhancer Sales (K Units) by Application (2020-2025)

 Table 61. Global NAD+ Enhancer Sales (K Units) by Application (2026-2031)

 Table 62. Global NAD+ Enhancer Sales Market Share by Application (2020-2025)

 Table 63. Global NAD+ Enhancer Sales Market Share by Application (2026-2031)

 Table 64. Global NAD+ Enhancer Revenue (US$ Million) by Application (2020-2025)

 Table 65. Global NAD+ Enhancer Revenue (US$ Million) by Application (2026-2031)

 Table 66. Global NAD+ Enhancer Revenue Market Share by Application (2020-2025)

 Table 67. Global NAD+ Enhancer Revenue Market Share by Application (2026-2031)

 Table 68. Global NAD+ Enhancer Price (US$/Unit) by Application (2020-2025)

 Table 69. Global NAD+ Enhancer Price (US$/Unit) by Application (2026-2031)

 Table 70. GeneHarbor Company Information

 Table 71. GeneHarbor Description and Business Overview

 Table 72. GeneHarbor NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 73. GeneHarbor NAD+ Enhancer Product

 Table 74. GeneHarbor Recent Developments/Updates

 Table 75. Chromadex Company Information

 Table 76. Chromadex Description and Business Overview

 Table 77. Chromadex NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 78. Chromadex NAD+ Enhancer Product

 Table 79. Chromadex Recent Developments/Updates

 Table 80. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Company Information

 Table 81. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Description and Business Overview

 Table 82. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 83. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Product

 Table 84. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Developments/Updates

 Table 85. Herbalmax Company Information

 Table 86. Herbalmax Description and Business Overview

 Table 87. Herbalmax NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 88. Herbalmax NAD+ Enhancer Product

 Table 89. Herbalmax Recent Developments/Updates

 Table 90. EffePharm Company Information

 Table 91. EffePharm Description and Business Overview

 Table 92. EffePharm NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 93. EffePharm NAD+ Enhancer Product

 Table 94. EffePharm Recent Developments/Updates

 Table 95. Kingdomway Company Information

 Table 96. Kingdomway Description and Business Overview

 Table 97. Kingdomway NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 98. Kingdomway NAD+ Enhancer Product

 Table 99. Kingdomway Recent Developments/Updates

 Table 100. NOMON Co., Ltd. (Teijin) Company Information

 Table 101. NOMON Co., Ltd. (Teijin) Description and Business Overview

 Table 102. NOMON Co., Ltd. (Teijin) NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 103. NOMON Co., Ltd. (Teijin) NAD+ Enhancer Product

 Table 104. NOMON Co., Ltd. (Teijin) Recent Developments/Updates

 Table 105. CELFULL Company Information

 Table 106. CELFULL Description and Business Overview

 Table 107. CELFULL NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 108. CELFULL NAD+ Enhancer Product

 Table 109. CELFULL Recent Developments/Updates

 Table 110. Bontac Company Information

 Table 111. Bontac Description and Business Overview

 Table 112. Bontac NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 113. Bontac NAD+ Enhancer Product

 Table 114. Bontac Recent Developments/Updates

 Table 115. Genex Formulas Company Information

 Table 116. Genex Formulas Description and Business Overview

 Table 117. Genex Formulas NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 118. Genex Formulas NAD+ Enhancer Product

 Table 119. Genex Formulas Recent Developments/Updates

 Table 120. EZZ Company Information

 Table 121. EZZ Description and Business Overview

 Table 122. EZZ NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 123. EZZ NAD+ Enhancer Product

 Table 124. EZZ Recent Developments/Updates

 Table 125. Maac10 Formulas Company Information

 Table 126. Maac10 Formulas Description and Business Overview

 Table 127. Maac10 Formulas NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 128. Maac10 Formulas NAD+ Enhancer Product

 Table 129. Maac10 Formulas Recent Developments/Updates

 Table 130. Elysium Health Company Information

 Table 131. Elysium Health Description and Business Overview

 Table 132. Elysium Health NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 133. Elysium Health NAD+ Enhancer Product

 Table 134. Elysium Health Recent Developments/Updates

 Table 135. Key Raw Materials Lists

 Table 136. Raw Materials Key Suppliers Lists

 Table 137. NAD+ Enhancer Distributors List

 Table 138. NAD+ Enhancer Customers List

 Table 139. NAD+ Enhancer Market Trends

 Table 140. NAD+ Enhancer Market Drivers

 Table 141. NAD+ Enhancer Market Challenges

 Table 142. NAD+ Enhancer Market Restraints

 Table 143. Research Programs/Design for This Report

 Table 144. Key Data Information from Secondary Sources

 Table 145. Key Data Information from Primary Sources

 Table 146. Authors List of This Report

List of Figures

 Figure 1. Product Picture of NAD+ Enhancer

 Figure 2. Global NAD+ Enhancer Market Value Comparison by Type (2020-2031) & (US$ Million)

 Figure 3. Global NAD+ Enhancer Market Share by Type: 2024 & 2031

 Figure 4. Content ＜98% Product Picture

 Figure 5. Content ≥98% Product Picture

 Figure 6. Global NAD+ Enhancer Market Value by Application (2020-2031) & (US$ Million)

 Figure 7. Global NAD+ Enhancer Market Share by Application: 2024 & 2031

 Figure 8. Health Care Products

 Figure 9. ClinicsBeauty Products

 Figure 10. Others

 Figure 11. Global NAD+ Enhancer Revenue, (US$ Million), 2020 VS 2024 VS 2031

 Figure 12. Global NAD+ Enhancer Market Size (2020-2031) & (US$ Million)

 Figure 13. Global NAD+ Enhancer Sales (2020-2031) & (K Units)

 Figure 14. Global NAD+ Enhancer Average Price (US$/Unit) & (2020-2031)

 Figure 15. NAD+ Enhancer Report Years Considered

 Figure 16. NAD+ Enhancer Sales Share by Manufacturers in 2024

 Figure 17. Global NAD+ Enhancer Revenue Share by Manufacturers in 2024

 Figure 18. Global 5 and 10 Largest NAD+ Enhancer Players: Market Share by Revenue in NAD+ Enhancer in 2024

 Figure 19. NAD+ Enhancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

 Figure 20. Global NAD+ Enhancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

 Figure 21. North America NAD+ Enhancer Sales Market Share by Country (2020-2031)

 Figure 22. North America NAD+ Enhancer Revenue Market Share by Country (2020-2031)

 Figure 23. United States NAD+ Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 24. Canada NAD+ Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 25. Europe NAD+ Enhancer Sales Market Share by Country (2020-2031)

 Figure 26. Europe NAD+ Enhancer Revenue Market Share by Country (2020-2031)

 Figure 27. Germany NAD+ Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 28. France NAD+ Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 29. U.K. NAD+ Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 30. Italy NAD+ Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 31. Russia NAD+ Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 32. Asia Pacific NAD+ Enhancer Sales Market Share by Region (2020-2031)

 Figure 33. Asia Pacific NAD+ Enhancer Revenue Market Share by Region (2020-2031)

 Figure 34. China NAD+ Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 35. Japan NAD+ Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 36. South Korea NAD+ Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 37. India NAD+ Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 38. Australia NAD+ Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 39. China Taiwan NAD+ Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 40. Southeast Asia NAD+ Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 41. Latin America NAD+ Enhancer Sales Market Share by Country (2020-2031)

 Figure 42. Latin America NAD+ Enhancer Revenue Market Share by Country (2020-2031)

 Figure 43. Mexico NAD+ Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 44. Brazil NAD+ Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 45. Argentina NAD+ Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 46. Middle East and Africa NAD+ Enhancer Sales Market Share by Country (2020-2031)

 Figure 47. Middle East and Africa NAD+ Enhancer Revenue Market Share by Country (2020-2031)

 Figure 48. Turkey NAD+ Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 49. Saudi Arabia NAD+ Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 50. UAE NAD+ Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 51. Global Sales Market Share of NAD+ Enhancer by Type (2020-2031)

 Figure 52. Global Revenue Market Share of NAD+ Enhancer by Type (2020-2031)

 Figure 53. Global NAD+ Enhancer Price (US$/Unit) by Type (2020-2031)

 Figure 54. Global Sales Market Share of NAD+ Enhancer by Application (2020-2031)

 Figure 55. Global Revenue Market Share of NAD+ Enhancer by Application (2020-2031)

 Figure 56. Global NAD+ Enhancer Price (US$/Unit) by Application (2020-2031)

 Figure 57. NAD+ Enhancer Value Chain

 Figure 58. Channels of Distribution (Direct Vs Distribution)

 Figure 59. Bottom-up and Top-down Approaches for This Report

 Figure 60. Data Triangulation

 Figure 61. Key Executives Interviewed